{"DataElement":{"publicId":"3553715","version":"1","preferredName":"Lesion Radiologic Assessment Criterion Name","preferredDefinition":"Text identification of the set of criteria used to assess a radiographic assessment of a lesion.","longName":"LES_RAD_ASSM_CRIT_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3553714","version":"1","preferredName":"Lesion Radiologic Assessment Criterion","preferredDefinition":"Any observable abnormal structural change in a bodily part._The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease._The final result of a determination of the value, significance, or extent of._Criteria; a basis for comparison; a reference point against which other things can be evaluated.","longName":"LES_RAD_ASSM_CRIT","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2732373","version":"1","preferredName":"Lesion","preferredDefinition":"Any observable abnormal structural change in a bodily part.","longName":"C71163","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C71163","definition":"Any observable abnormal structural change in a bodily part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"473F6908-3F10-001F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-02-28","modifiedBy":"ONEDATA","dateModified":"2008-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3553712","version":"1","preferredName":"Radiology Assessment Criterion","preferredDefinition":"The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.:The final result of a determination of the value, significance, or extent of.:Criteria; a basis for comparison; a reference point against which other things can be evaluated.","longName":"C17059:C0679207:C25466","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiology","conceptCode":"C17059","definition":"The branch of medical science dealing with the medical use of X-rays or other penetrating radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C0679207","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-0954-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-0965-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3553709","version":"1","preferredName":"Radiography Lesion Assessment Criterion Name","preferredDefinition":"A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._The final result of a determination of the value, significance, or extent of._Criteria; a basis for comparison; a reference point against which other things can be evaluated._The words or language units by which a thing is known.","longName":"RAD_LES_ASSM_CRIT_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MacDonald","valueDescription":"MacDonald criteria","ValueMeaning":{"publicId":"3553710","version":"1","preferredName":"MacDonald criteria","longName":"3553710","preferredDefinition":"A set of diagnostic criteria for multiple sclerosis (MS) diagnosis using magnetic-resonance imaging (MRI) techniques","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-090A-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6EE4F6C-0923-4E7F-E040-BB89AD430BCD","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"RANO","valueDescription":"Response assessment in neuro-oncology patients (RANO)","ValueMeaning":{"publicId":"3553711","version":"1","preferredName":"Response assessment in neuro-oncology patients (RANO)","longName":"3553711","preferredDefinition":"A set of guidelines for assessing response to therapy in high-grade gliomas","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-092D-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6EE4F6C-0946-4E7F-E040-BB89AD430BCD","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"2838911","version":"1","preferredName":"Not Applicable","longName":"2838911","preferredDefinition":"Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A641-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"CLOHNES","dateModified":"2022-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2BA403-2E46-66AD-E040-BB89AD4350F2","beginDate":"2013-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"RECIST 1.1","valueDescription":"Response Evaluation Criteria in Solid Tumors","ValueMeaning":{"publicId":"2627734","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors","longName":"2627734","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E04FCDB-148F-1B41-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-04-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC2BA403-2E5A-66AD-E040-BB89AD4350F2","beginDate":"2013-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-07","modifiedBy":"ONEDATA","dateModified":"2013-05-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1DB169B7-59F6-77F9-E050-BB89AD434B69","beginDate":"2015-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-19","modifiedBy":"ONEDATA","dateModified":"2015-08-19","deletedIndicator":"No"},{"value":"PET","valueDescription":"Positron Emission Tomography","ValueMeaning":{"publicId":"2919109","version":"1","preferredName":"Positron Emission Tomography","longName":"2919109","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EAE3776-A836-6030-E040-BB89AD432E08","latestVersionIndicator":"Yes","beginDate":"2009-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-14","modifiedBy":"KUMMEROA","dateModified":"2023-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1DB169B7-5A00-77F9-E050-BB89AD434B69","beginDate":"2015-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-19","modifiedBy":"ONEDATA","dateModified":"2015-08-19","deletedIndicator":"No"},{"value":"Immune related response criteria (IrRC)","valueDescription":"Immune Related Response Criterion","ValueMeaning":{"publicId":"4566773","version":"1","preferredName":"Immune Related Response Criterion","longName":"4566773","preferredDefinition":"A measure proposed by Wolchok et al. (Clin Cancer Res 2009;15:7412-7420) to determine the extent of an antitumor response to a particular immunotherapeutic agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Overall Immune Related Response Criterion","conceptCode":"C111082","definition":"A measure proposed by Wolchok et al. (Clin Cancer Res 2009;15:7412-7420) to determine the extent of an antitumor response to a particular immunotherapeutic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"06A42434-BBB8-5020-E050-BB89AD43584A","latestVersionIndicator":"Yes","beginDate":"2014-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1DB169B7-5A14-77F9-E050-BB89AD434B69","beginDate":"2015-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-19","modifiedBy":"ONEDATA","dateModified":"2015-08-19","deletedIndicator":"No"},{"value":"RECIST 1.0","valueDescription":"Version One Response Evaluation Criteria in Solid Tumors","ValueMeaning":{"publicId":"4975611","version":"1","preferredName":"Version One Response Evaluation Criteria in Solid Tumors","longName":"4975611","preferredDefinition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Version","conceptCode":"C25714","definition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DB169B7-5A23-77F9-E050-BB89AD434B69","latestVersionIndicator":"Yes","beginDate":"2015-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1DB169B7-5A3C-77F9-E050-BB89AD434B69","beginDate":"2015-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-08-19","modifiedBy":"ONEDATA","dateModified":"2015-08-19","deletedIndicator":"No"},{"value":"iRANO","valueDescription":"Immunotherapy Response Assessment in Neuro-Oncology Criteria","ValueMeaning":{"publicId":"5914107","version":"1","preferredName":"Immunotherapy Response Assessment in Neuro-Oncology Criteria","longName":"5914107","preferredDefinition":"Response assessment criteria for the evaluation of patients undergoing immunotherapy for the treatment of malignant glioma. These recommendations integrate guidance for the determination and confirmation of tumor progression based on the response assessment in neuro-oncology (RANO) working group and the immune-related response criteria (irRC).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy Response Assessment in Neuro-Oncology Criteria","conceptCode":"C131131","definition":"Response assessment criteria for the evaluation of patients undergoing immunotherapy for the treatment of malignant glioma. These recommendations integrate guidance for the determination and confirmation of tumor progression based on the response assessment in neuro-oncology (RANO) working group and the immune-related response criteria (irRC).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54A09267-EE80-6E45-E053-F662850A7CBF","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5900F3A2-8BA0-335A-E053-F662850AC6F8","beginDate":"2017-09-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-09-12","modifiedBy":"ONEDATA","dateModified":"2017-09-12","deletedIndicator":"No"},{"value":"RANO-BM","valueDescription":"Response Assessment in Neuro-Oncology Brain Metastases","ValueMeaning":{"publicId":"7359783","version":"1","preferredName":"Response Assessment in Neuro-Oncology Brain Metastases","longName":"7359783","preferredDefinition":"A working group that is leading an international, multidisciplinary effort to develop standard response and progression criteria for use in clinical trials of treatment for brain metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Assessment in Neuro-Oncology Brain Metastases","conceptCode":"C173572","definition":"A working group that is leading an international, multidisciplinary effort to develop standard response and progression criteria for use in clinical trials of treatment for brain metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AADE75E4-DA41-427C-E053-4EBD850AA09A","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AADE75E4-DA5A-427C-E053-4EBD850AA09A","beginDate":"2020-07-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3553708","version":"1","preferredName":"Radiography Lesion Assessment Criterion Name","preferredDefinition":"A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:The final result of a determination of the value, significance, or extent of.:Criteria; a basis for comparison; a reference point against which other things can be evaluated.:The words or language units by which a thing is known.","longName":"3553708v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Ray Imaging","conceptCode":"C38101","definition":"A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C0679207","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-08E6-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"ONEDATA","dateModified":"2012-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-08F7-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"KUMMEROA","dateModified":"2020-07-20","changeDescription":"2020-7-20 PV added for DCI. AK Addition of RECIST 1.0, IrRC, PET and Other for ER_DCI_08.19.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"CTEP","type":"USED_BY","context":"CTEP"}],"ReferenceDocuments":[{"name":"Lesion Assessment Criteria","type":"Preferred Question Text","description":"Lesion Assessment Criteria","url":null,"context":"NCIP"},{"name":"Criteria for Measuring Response","type":"Alternate Question Text","description":"Criteria for Measuring Response","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6EE4F6C-0976-4E7F-E040-BB89AD430BCD","latestVersionIndicator":"Yes","beginDate":"2012-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-10","modifiedBy":"HARTLEYG","dateModified":"2015-08-19","changeDescription":"Curated to support Duke University Recursive Partitioning Assessment study","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}